| Lactose (India) Ltd | 159 Cr. | 126 | 247/84.3 | 35.2 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,728 Cr. | 434 | 479/192 | 97.9 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.5 Cr. | 43.8 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 38.8 Cr. | 26.5 | 29.1/17.0 | 92.4 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.4 Cr. | 82.9 | 134/78.3 | 16.9 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 52,096 Cr. | 1,843 | 2,286/1,275 | 20.7 | 340 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 337 Cr. | 14.6 | 19.9/10.8 | 20.2 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 914 Cr. | 1,935 | 1,971/635 | 31.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 110 Cr. | 21.9 | 32.0/15.5 | 29.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 814 Cr. | 277 | 449/219 | 7.27 | 133 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 10.3 Cr. | 4.13 | 9.28/2.11 | 5.84 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 422 Cr. | 434 | 477/117 | 63.7 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,937 Cr. | 1,134 | 1,565/1,038 | 44.7 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.24/0.26 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 41.4 Cr. | 17.2 | 26.3/6.54 | 42.7 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.9 Cr. | 10.8 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 183 Cr. | 513 | 859/443 | 10.4 | 596 | 0.29 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 87.2 Cr. | 87.2 | 92.5/26.1 | 164 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,715 Cr. | 1,501 | 2,452/1,345 | 48.9 | 174 | 0.71 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.7 Cr. | 43.1 | 88.7/36.1 | 42.8 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 16.4 Cr. | 6.56 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.7 Cr. | 118 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 46.4 Cr. | 84.8 | 84.8/9.41 | 32.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.1 Cr. | 40.0 | 80.0/0.00 | 48.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.95 Cr. | 23.2 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,900 Cr. | 571 | 1,028/492 | 28.1 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.1 Cr. | 20.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.9 Cr. | 23.4 | 43.7/17.4 | 51.6 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,005 Cr. | 2,227 | 3,055/2,115 | 55.2 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 224 Cr. | 389 | 524/241 | 23.0 | 123 | 1.16 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 47.5 Cr. | 33.1 | 62.6/26.7 | 74.2 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 72,598 Cr. | 1,239 | 1,365/994 | 21.2 | 598 | 0.32 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 139 Cr. | 223 | 303/159 | 133 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 808 Cr. | 80.9 | 123/74.0 | 20.9 | 32.6 | 1.85 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.5 Cr. | 29.5 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,025 Cr. | 1,714 | 1,868/919 | 62.6 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.97 Cr. | 0.60 | 1.45/0.55 | 99.2 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 235 Cr. | 30.6 | 68.0/30.0 | 15.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 6.20 Cr. | 10.6 | 23.8/9.40 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 133 Cr. | 5.64 | 6.57/2.82 | 309 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,946 Cr. | 29,665 | 37,000/25,260 | 41.7 | 1,888 | 1.60 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,456 Cr. | 712 | 972/550 | 26.9 | 226 | 0.70 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 273 Cr. | 95.1 | 100/31.3 | 76.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,776 Cr. | 1,575 | 1,633/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,839 Cr. | 1,344 | 1,870/1,110 | 398 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 818 Cr. | 233 | 330/154 | 19.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 740 Cr. | 555 | 590/270 | 11.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,361 Cr. | 477 | 908/438 | 23.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,603 Cr. | 1,126 | 1,595/991 | 22.7 | 768 | 0.89 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,28,381 Cr. | 3,791 | 3,882/2,886 | 59.3 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,051 Cr. | 114 | 310/98.0 | | 41.3 | 0.44 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,538 Cr. | 16.4 | 24.0/14.1 | 24.5 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 22,829 Cr. | 596 | 1,360/593 | 66.5 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,071 Cr. | 179 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,22,043 Cr. | 1,759 | 1,910/1,547 | 36.6 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,556 Cr. | 574 | 886/441 | 399 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,675 Cr. | 285 | 329/175 | 33.0 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 405 Cr. | 1,333 | 1,680/956 | 21.7 | 683 | 0.11 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,064 Cr. | 365 | 502/265 | 45.7 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 6,256 Cr. | 248 | 250/111 | 145 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,530 Cr. | 4,575 | 6,718/4,146 | 28.5 | 340 | 2.56 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,799 Cr. | 2,300 | 2,725/1,772 | 34.1 | 335 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,794 Cr. | 5,890 | 6,739/4,904 | 31.9 | 373 | 2.12 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 166 Cr. | 47.0 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,934 Cr. | 5,010 | 5,993/3,701 | 32.4 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 116 Cr. | 94.1 | 348/81.0 | 12.0 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,313 Cr. | 378 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,273 Cr. | 842 | 1,998/604 | 81.8 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,131 Cr. | 17,250 | 19,748/10,060 | 113 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 307 Cr. | 13.7 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,597 Cr. | 815 | 1,505/660 | 9.49 | 483 | 0.74 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,507 Cr. | 45.7 | 91.7/41.7 | 33.2 | 21.8 | 0.44 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,726 Cr. | 192 | 359/162 | 24.8 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 95.9 Cr. | 61.2 | 130/58.6 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 298 Cr. | 83.2 | 177/82.9 | 146 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 93,536 Cr. | 2,047 | 2,403/1,774 | 21.6 | 430 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,071 Cr. | 534 | 980/490 | 13.4 | 357 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,331 Cr. | 1,007 | 1,034/482 | 79.6 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 990 Cr. | 954 | 1,235/596 | 20.2 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 141 Cr. | 67.1 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 655 Cr. | 136 | 236/136 | 37.2 | 104 | 2.21 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 617 Cr. | 355 | 500/265 | 22.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 18,086 Cr. | 1,135 | 1,265/802 | 36.4 | 414 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,138 Cr. | 1,798 | 1,952/1,303 | 39.2 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,410 Cr. | 211 | 328/193 | 32.2 | 38.0 | 1.18 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,145 Cr. | 1,423 | 1,758/1,168 | 36.5 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,753 Cr. | 93.5 | 127/57.5 | 23.7 | 59.7 | 0.86 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 787 Cr. | 96.6 | 124/67.2 | 26.5 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,466 Cr. | 268 | 355/190 | | 106 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,820 Cr. | 229 | 465/225 | 279 | 96.9 | 0.61 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,435 Cr. | 1,687 | 2,768/1,243 | 32.7 | 397 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,288 Cr. | 329 | 498/285 | 60.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,631 Cr. | 561 | 628/412 | 26.7 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 52,096 Cr. | 1,843 | 2,286/1,275 | 20.7 | 340 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,180 Cr. | 2,488 | 3,516/1,921 | 44.2 | 101 | 1.69 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,504 Cr. | 1,790 | 2,131/1,200 | 25.5 | 610 | 1.01 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,661 Cr. | 410 | 530/359 | 29.6 | 149 | 1.22 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,476 Cr. | 1,576 | 1,910/1,097 | 51.6 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,802 Cr. | 1,244 | 1,406/1,020 | 18.0 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,903 Cr. | 249 | 322/178 | 26.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,285 Cr. | 1,514 | 1,673/1,310 | 22.5 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,545 Cr. | 1,915 | 2,641/1,551 | 24.7 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 308 Cr. | 105 | 203/95.6 | 22.0 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,753 Cr. | 166 | 191/105 | 16.0 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 63.0 Cr. | 38.8 | 72.0/37.7 | 22.1 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 56,320 Cr. | 422 | 425/291 | 119 | 200 | 0.12 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,669 Cr. | 1,653 | 2,190/1,430 | 36.9 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 127 Cr. | 79.1 | 141/76.3 | 18.6 | 49.2 | 1.52 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 411 Cr. | 174 | 205/67.8 | 38.9 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,614 Cr. | 9,038 | 10,691/6,220 | 97.8 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,044 Cr. | 705 | 843/544 | 36.0 | 118 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 171 Cr. | 81.1 | 137/79.0 | 9.09 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,307 Cr. | 5,713 | 5,868/4,492 | 29.1 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,979 Cr. | 914 | 1,124/725 | 28.3 | 271 | 1.20 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 465 Cr. | 812 | 1,540/763 | | 690 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 30,719 Cr. | 2,458 | 3,116/2,022 | 31.6 | 345 | 1.14 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,707 Cr. | 330 | 412/258 | 25.2 | 133 | 1.57 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,145 Cr. | 451 | 575/312 | 21.8 | 146 | 0.22 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,251.51 Cr | 1,187.41 | | 53.46 | 202.47 | 0.34% | 16.24% | 14.95% | 6.10 |